Unclaimed brand
Accelerate cancer immunotherapy and cancer vaccine development with Alithea Bio's HLA immunopeptidomics platform — neoantigen discovery, TCR validation & off-target safety profiling.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#FF7732
Burning Orange
255, 119, 50
20, 100, 60
0, 53, 80, 0
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#333333
Mine Shaft
51, 51, 51
0, 0, 20
0, 0, 0, 80
Alithea Bio is a precision immunotherapy company that specializes in fine-tuning immunotherapy treatment. They have developed a comprehensive HLA peptide database consisting of over 3000 high-quality samples from healthy organs, cancer cell lines, and tumor tissue. This valuable resource, supported by a quantitative bioinformatics process, allows researchers to study HLA peptide presentation in both health and disease.
Alithea Bio's highly sensitive and reproducible HLA peptidome characterization supports the development of various therapeutic options, particularly in the field of immunotherapy. Their technology enables target discovery and validation, quality control and safety assessment, and immunogenicity evaluation. Additionally, Alithea Bio offers innovative solutions like NEOZOOM™, a strategy that revolutionizes neoantigen discovery, and CONZOOM™, a technology for targeted epitope discovery.
With their laboratories located in a biotech hotspot in central Europe, Alithea Bio is committed to advancing precision immunotherapy and making a positive impact on patient care
Company type
Privately Held
Year founded
2019
Company size
2-10 employees
The Alithea Bio name, logos and brand assets are trademarks of Alithea Bio and its affiliates. Brandfetch isn't affiliated with or endorsed by Alithea Bio. Their use is subject to Alithea Bio's brand guidelines.
